Chronic Opioid Therapy in People Living With Human Immunodeficiency Virus: Patients’ Perspectives on Risks, Monitoring, and Guidelines | Zendy

Jonathan Colasanti | Zendy; Marlene C. Lira | Zendy; Debbie M. Cheng | Zendy; Jane M. Liebschutz | Zendy; Judith I. Tsui | Zendy; Leah S. Forman | Zendy; Meg Sullivan | Zendy; Alexander Y. Walley | Zendy; Carly Bridden | Zendy; Christin Root | Zendy; Melissa C. Podolsky | Zendy; Catherine Abrams | Zendy; Kishna Outlaw | Zendy; Catherine E. Harris | Zendy; Wendy S. Armstrong | Zendy; Jeffrey H. Samet | Zendy; Carlos del Rı́o | Zendy

Open Access

Chronic Opioid Therapy in People Living With Human Immunodeficiency Virus: Patients’ Perspectives on Risks, Monitoring, and Guidelines

Author(s) -

Jonathan Colasanti,

Marlene C. Lira,

Debbie M. Cheng,

Jane M. Liebschutz,

Judith I. Tsui,

Leah S. Forman,

Meg Sullivan,

Alexander Y. Walley,

Carly Bridden,

Christin Root,

Melissa C. Podolsky,

Catherine Abrams,

Kishna Outlaw,

Catherine E. Harris,

Wendy S. Armstrong,

Jeffrey H. Samet,

Carlos del Rı́o

Publication year - 2018

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciy452

Subject(s) - medicine , opioid , interquartile range , pill , guideline , medical prescription , addiction , psychiatry , pharmacology , receptor , pathology

Chronic opioid therapy (COT) is common in people living with human immunodeficiency virus (PLHIV), but is not well studied. We assessed opioid risk behaviors, perceptions of risk, opioid monitoring, and associated Current Opioid Misuse Measure (COMM) scores of PLHIV on COT.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research